Alex van Egerschot

Alex studied Medical Biology and obtained his master’s degree in 2020 after which he worked for two years at the headquarters of a pharmaceutical company, supporting the pharmacovigilance and medical information department. In 2022 he joined DADA as a Junior Consultant Pharmacovigilance in the Safety Data Management team within the DADA Pharmacovigilance department. His primary tasks involve managing safety information for DADA’s clients’ medicinal products and the global and local literature screening process.